ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck expands its venture fund

by Ann M. Thayer
June 13, 2016 | APPEARED IN VOLUME 94, ISSUE 24

Merck KGaA has doubled the size of its existing corporate venture fund and expanded it beyond the biopharmaceutical area, to cover all three of the company’s businesses. Now worth up to $340 million, Merck Ventures will have teams dedicated to investing in the health care, life sciences, and performance materials areas as well as in entirely new businesses. The teams can participate in seed-stage company start-up, early-stage syndicated investments, and Merck spin-off creation and funding.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment